Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-10

Clinical Trial Update: Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

View source ↗

Summary

This completed study assessed caregivers' and physicians' treatment preferences for Parkinson's disease patients treated with Neupro (rotigotine) who require ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Idiopathic Parkinson's Disease | Status: COMPLETED | Results posted: 2013-12-10